The Reversal of Direct Oral Anticoagulants in Animal Models

Shock - United States
doi 10.1097/shk.0000000000000848
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Reversal of Direct Oral Anticoagulants in Hemophilia Treatment

Memo - Magazine of European Medical Oncology
OncologyHematology
2016English

Reversal of Direct Oral Anticoagulants: Guidance From the Anticoagulation Forum

American Journal of Hematology
Hematology
2019English

Introduction to Direct Oral Anticoagulants and Rationale for Specific Reversal Agents

American Journal of Emergency Medicine
MedicineEmergency Medicine
2016English

Reversal of Direct Oral Anticoagulants for Liver Transplantation in Cirrhosis: A Step Forward

Liver Transplantation
HepatologyTransplantationSurgery
2017English

Direct Oral Anticoagulants (DOACs)

Vascular Medicine
MedicineCardiovascular MedicineCardiology
2015English

Direct Oral Anticoagulants: First Airbag

Medical Council
2019English

Bleeding Complications From the Direct Oral Anticoagulants

BMC Hematology
HematologyMolecular Biology
2015English

A New Generation of Oral Direct Anticoagulants

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2012English

Direct Oral Anticoagulants (DOAC) in Oral Implant Surgery - A Metaanalysis

Clinical Oral Implants Research
Oral Surgery
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy